Nektar Therapeutics (NKTR) News
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
41.17+0.37 (+0.91%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NKTR news summary
We found 1 recent headline mentioning Nektar Therapeutics (NKTR): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, NKTR is up 0.91% at $41.17. The most recent story, "Raymond James Initiates Coverage of Nektar Therapeutics with Market Perform", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology